Market Overview

Anavex Life Down 14% After Subpoena Disclosure


Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) plummeted more than 14 percent on Tuesday.

Anavex Life Sciences disclosed earlier in the day an SEC subpoena and formal investigation in a 10-K filing, which may be related to unusual activity in the company's stock.

"On December 22, 2015, the Company received a subpoena from the Securities and Exchange Commission (SEC) which indicates that the agency is conducting a formal investigation," Avanex Life Sciences said in its 10-K filing. "The Company believes the subpoena and investigation relate to the recent unusual activity in the market for the Company's shares. The Company is fully cooperating with the SEC in this investigation and is unable to predict when this matter will be resolved or what further action, if any, the SEC may take in connection with it."

The stock traded recently at $5.99, down 14.7 percent.


Related Articles (AVXL)

View Comments and Join the Discussion!

Posted-In: 10-K Anavex Life Sciences SEC InvestigationNews Legal Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at